These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19263063)

  • 1. Weekly intramuscular methotrexate in the treatment of low-risk gestational trophoblastic neoplasia.
    Mohit M; Sarraf Z; Sheikhi G; Robati M; Vasheghani-Farahani A
    Arch Gynecol Obstet; 2009 Nov; 280(5):775-80. PubMed ID: 19263063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease.
    Homesley HD; Blessing JA; Rettenmaier M; Capizzi RL; Major FJ; Twiggs LB
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):413-8. PubMed ID: 2457192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia.
    Kwon JS; Elit L; Mazurka J; Moens F; Schmuck ML
    Gynecol Oncol; 2001 Aug; 82(2):367-70. PubMed ID: 11531296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia: a Gynecologic Oncology Group study.
    Covens A; Filiaci VL; Burger RA; Osborne R; Chen MD;
    Cancer; 2006 Sep; 107(6):1280-6. PubMed ID: 16900525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of pulse methotrexate and pulse dactinomycin in the treatment of low-risk gestational trophoblastic neoplasia.
    Gilani MM; Yarandi F; Eftekhar Z; Hanjani P
    Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):161-4. PubMed ID: 15760322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The WHO score predicts treatment outcome in low risk gestational trophoblastic neoplasia patients treated with weekly intramuscular methotrexate.
    Gilani MM; Fariba B; Behtash N; Ghaemmaghami F; Moosavi AS; Rezayof E
    J Cancer Res Ther; 2013; 9(1):38-43. PubMed ID: 23575072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.
    Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
    Gynecol Oncol; 2009 Feb; 112(2):353-7. PubMed ID: 19059633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof].
    Chen YX; Shen YM; Qian JH; Xie X
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia.
    Chan KK; Huang Y; Tam KF; Tse KY; Ngan HY
    Am J Obstet Gynecol; 2006 Nov; 195(5):1282-6. PubMed ID: 16723109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Outcome of gestational trophoblastic neoplasia patients with residual lung tumor after completion of treatment].
    Yang JJ; Xiang Y; Wan XR; Li JG; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):26-8. PubMed ID: 17331417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent gestational trophoblastic tumor: management and risk factors for recurrence.
    Yang J; Xiang Y; Wan X; Yang X
    Gynecol Oncol; 2006 Nov; 103(2):587-90. PubMed ID: 16750258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease.
    Hoffman MS; Fiorica JV; Gleeson NC; Roberts WS; Cavanagh D
    Gynecol Oncol; 1996 Feb; 60(2):292-4. PubMed ID: 8631554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A conservative approach in persistent low-level elevation of serum beta-human chorionic gonadotropin following chemotherapy for gestational trophoblastic neoplasia.
    Boafo-Yirenki M; Everard J; Tidy J; Hancock BW
    J Reprod Med; 2009 May; 54(5):288-90. PubMed ID: 19517692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia.
    Kang WD; Choi HS; Kim SM
    Gynecol Oncol; 2010 Jun; 117(3):477-80. PubMed ID: 20347479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
    Lurain JR; Nejad B
    Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Single methotrexate chemotherapy for low-risk gestational trophoblastic tumor].
    Lu WG; Ding ZM; Xie X; Ye DF; Chen HZ; Feng SW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):414-7. PubMed ID: 12974085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens.
    Abrão RA; de Andrade JM; Tiezzi DG; Marana HR; Candido dos Reis FJ; Clagnan WS
    Gynecol Oncol; 2008 Jan; 108(1):149-53. PubMed ID: 17931696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical parameters predicting therapeutic response to surgical management in patients with chemotherapy-resistant gestational trophoblastic neoplasia.
    Feng F; Xiang Y; Li L; Wan X; Yang X
    Gynecol Oncol; 2009 Jun; 113(3):312-5. PubMed ID: 19345988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-risk gestational trophoblastic neoplasia: evaluating the need for initial inpatient treatment during low-dose methotrexate chemotherapy.
    Carter LD; Hancock BW; Everard JE
    J Reprod Med; 2008 Jul; 53(7):525-7. PubMed ID: 18720928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.